Today menopausal – direct consequence of the removal of the ovaries in March after a double mastectomy two years ago – Angelina Jolie hopes inform women about the preventive fight against cancer. A recent study also shows the impact of its operations on women. The researchers even speak of an “Angelina effect” on these preventive mastectomies.
In May 2013, the American star received the results of a blood announcing that it had 83% chance of developing breast cancer. This double preventive mastectomy was heavily hyped
Carrier BRCA1 which exposes it to a higher risk of developing ovarian cancer, the actress had made the decision to have surgery. This year in March, following the advice of her doctor, she chose to undergo removal of the ovaries and fallopian tubes. It is in an open letter published by the New York Times , she had made the announcement. Nearly seven months later, she looks back on his early menopause triggered by this operation.
When she reached the forties in June, Angelina says in an interview with the newspaper Australian The Daily Telegraph , that she “loves being menopausal.” “I have not had a bad reaction so I’m lucky. I feel older and I feel good like this. I’m happy to have aged, I did not want to be young again. ”
The extensive media coverage of its operations would have influenced many women who have since followed suit. In any case what emerges from a recent study published on November 25 by the journal Breast Cancer Research , which notes that the number of preventive mastectomies performed double in their center had doubled between January 2014 and June 2015. This is what the researchers called “Angelina effect.”
Its operations, however, are subject to debate and raise some questions. Is it really possible to anticipate cancer? According to Dr. Alexandra Leary, oncologist at the center Gustave Roussy in Villejuif, the answer is no. We can actually prevent cancer but anticipate is scientifically impossible. When questioned by the Huffington Post, she explains that “at present, under the supervision of this cancer is not effective so we can not promise to be able to detect at an early stage.”